Abstract: Ethylene glycol monoethyl ether (EGEE) can cause damage to testes and sperm, and its metabolites are believed to play an important role in its toxicity. Aldehyde dehydrogenase 2 (ALDH2) is involved in the metabolism of this chemical. To investigate whether and how the enzyme affects the toxicity of EGEE, we conducted experiments comparing Aldh2 knockout mice with wild-type mice. Administration of EGEE at 100 and 600 mg/kg/day for one week did not induce any significant change in the weight and body weight ratios of testes, prostate and epididymides in either Aldh2 knockout or wild-type mice. However, motion of sperm from the spermaduct, as analyzed with a Hamilton-Thorne Sperm analyzer, was slightly decreased in the low dose group, and significantly lower in the high dose group; and the percentage of progressive sperm was also reduced in the two EGEE groups. This effect of EGEE treatment was observed in the wild-type, but not in the Aldh2 knockout mice. Sperm motion from the cauda epididymides was not affected. On the other hand, the concentration of ethoxyacetic acid, a metabolite of EGEE, in 24 h pooled urine of EGEE-treated Aldh2 knockout mice was not significantly lower than that of the wild-type mice on most days of urine sampling. These results suggest that inactivation of the ALDH2 enzyme due to gene mutation may be linked to differences in the susceptibility to EGEE-induced sperm toxicity.
Ethylene glycol monoethyl ether (EGEE) is used as an industrial thinner and organic solvent for resins and dyes. It is known for toxicity on the male reproductive system, causing testicular atrophy and decreased sperm count in animals after repeated exposure to the solvent 1, 2) , and also retarded sperm motion 3) . EGEE is miscible with both water and other organic solvents, and can be easily absorbed through the skin as well as via inhalation. After entering the body, EGEE is first transformed to ethoxyacetaldehyde by alcohol dehydrogenase and other enzymes, and the inter-metabolite aldehyde is further metabolized by aldehyde dehydrogenase (ALDH) to ethoxyacetic acid (EAA) 4, 5) , The contributions of EGEE itself and its metabolites to reproductive toxicity are still unclear.
The biotransformation of EGEE plays an important role in the expression of its toxicity. ALDH2, one of the ALDH isozymes, is a major enzyme involved in the metabolism of many short chain aliphatic aldehydes including ethoxyacetic aldehyde 6, 7) . This isozyme is known to be polymorphic in the Asian population, and subjects bearing one or two of the mutant alleles have very low or almost no activity of aldehyde metabolism 7, 8) . Therefore, there may be some differences in the metabolic rates and metabolite profiles of EGEE in subjects with different genotypes, which might also be reflected in EGEE toxicity. To confirm this hypothesis, we used Aldh2 knockout mice as an ALDH2 inactive human model for detecting the influence of the polymorphisms of the Aldh2 gene on the reproductive toxicity of EGEE in males. Aldh2 knockout mice were created by transgenic knockout of the Aldh2 gene in mice of C57BL/6 background, and the knockout mice (Aldh2-/-) showed little in vitro activity with regard to aldehydes of low molecular weight in the mitochondrial fraction of the liver 6, 9) . Male Aldh2 knockout mice (Aldh2-/-) and mice of the wild-type C57BL/6 (Aldh2 +/+), 12 wk old, were used. Mice were administered EGEE (>98%, Wako Pure Chemicals, Osaka) by gavage at 100 or 600 mg/kg/day for 7 days. Mice of both genetic types were given saline as controls. After administration of EGEE at 10 a.m. each day, each mouse was housed in a single metabolic cage made of stainless steel, and urine was collected for 24 h on the first, second, fourth and seventh days of EGEE administration.
Mice were sacrificed 24 h after the last EGEE dosing under anesthesia. Blood samples were collected from the postcaval vein and the blood cells and hemoglobin concentration were determined using Celltac alpha (Nihon Kohden, Tokyo). Testes, epididymides and prostate were dissected and weighed. Sperm from the cauda epididymis and the spermaduct of one side were released into Medium 199 (Invitrogen, Carlsbad, CA, USA) containing 0.5% bovine serum albumin, and sperm motion was analyzed after 5 min incubation at 37°C using a Hamilton-Thorne Sperm Analyzer (HTM-IVOS, Hamilton Thorn Research, Inc., Beverly, MA, USA). Motility parameters such as percentage of motile sperm, percentage of progressively motile sperm, velocity parameters such as curvilinear velocity (VCL), average path velocity (VAP), and straight line velocity (VSL), parameters showing the swimming pattern of spermatozoa such as head movement (amplitude of lateral head displacement, ALH, and beat cross frequency, BCF), and parameters such as straightness (STR) and linearity (LIN), were measured.
EAA in urine was quantified by gas chromatography with a mass detector (Agilent, CA, USA) as previously reported 10) , and the metabolite was normalized to urinary creatinine as assayed by the Creatinine Test-Wako (Wako Pure Chemicals, Osaka).
Data were analyzed with one-way ANOVA, and comparisons of mean values were made using TukeyKramer's test. Differences between groups were considered significant for p<0.05.
Administration of EGEE for one week at 100 or 600 mg/ kg did not exert any effect on the weight ratios of testes, epididymides and prostate to body weight, in either wildtype or Aldh2 knockout mice (Table 1) . There was no difference in the weight ratios of these organs between Aldh2 Data represent the mean ± SD for 5-6 mice in each group. The sperm motility of sperm from the spermaduct was decreased by about 10% and 30% in the low and high EGEE dose groups of wild-type mice, respectively, with significant difference between the control and the high EGEE dose groups (Fig. 1 ). An effect of EGEE treatment on the percentage of progressive sperm was also observed in the wild-type mice, and the percentage of progressive sperm decreased by about 20% and 50% in the low and high EGEE dose groups, respectively (Fig. 2) . However, in Aldh2 knockout mice, neither the total motile percentage nor the percentage of progressive sperm in sperm from the spermaduct was affected in the two EGEE treatment groups.
In the wild-type mice, the proportion of sperm with rapid motion in the high EGEE dose group was decreased to 65% of that of the control, while the static sperm was markedly increased by 86% (Fig. 3) . These effects of EGEE were not seen in Aldh2 knockout mice. Significant changes in sperm velocity parameters (VCL, VAP, and VSL), and sperm swimming patterns (ALH and BCF) were not found after EGEE treatment in either the knockout or the wild-type mice (data not shown).
When the sperm parameters were compared between the knockout and wild-type mice, there was no significant difference for the two groups of controls, and the two groups of low-dose EGEE, but differences in total and progressive motility and sperm velocity parameters between the two genotype groups at high-dose EGEE were statistically significant, with more severe effect of EGEE in the wildtype mice (Figs. 1 and 2) . There was no significant difference in total and progressive motility, and in parameters of sperm velocity and swimming pattern between sperm from the epididymis of the wild-type and Aldh2 knockout mice (data not shown).
The urinary excretion of EAA was 2.96 and 3.12 mg/g creatinine in the controls of wild-type and knockout mice, respectively, on the first day. EAA excretion was higher by 116 and 78 folds, respectively, in the low dose group; and by 2,786 and 2,050 folds, respectively, in the high dose group. Within the same genetic type, the EAA excretion in urine increased in a dose-dependent manner on all days of urine sampling (though without significant difference between control and low dose group). However, the difference in the excretion rate between the two genetic types of mice was not statistically significant, except for that in the high dose of EGEE on the 7th day, when the urinary EAA concentration of the Aldh2 knockout mice was lower than that of the wildtype mice with statistical significance (Fig. 4) .
In this study, we found that the toxicity of EGEE on sperm can be affected by the activity of ALDH2, as shown by the differences between wild-type and knockout mice of the gene coding this enzyme. Moreover, the sperm motion was remarkably retarded by the present treatment regimen of EGEE, even though there was no evident atrophy in the reproductive organs of the wild-type mice, implying that the motion of sperm may serve as an early and sensitive index of reproductive toxicity.
EGEE can cause damage to the testes and sperm 3) , and its effect on sperm motion was confirmed in the present study with mice. The effects included decrease in motile sperm, retarded progressiveness, increase in static sperm, and they were shown in an EGEE dose-dependent way. However, these effects were only observed in the wild-type mice but not the Aldh2 knockout mice, indicating that the ALDH2 enzyme is involved in the metabolism of EGEE and may play a critical role in the reproductive toxicity of this compound in the body.
Although the mechanism underlying the reproductive toxicity of EGEE is not clearly understood [10] [11] [12] , it has been suggested that the final metabolite, EAA, may be a determinant [13] [14] [15] . Differences in EAA production, therefore, may cause different degrees of damage to sperm. To investigate the differences in the metabolic consequences of EGEE in the knockout and wild-type mice, 24-h urine was collected and pooled, and EAA was quantitatively analyzed. To our surprise, no differences in the excretion rates of EAA were found in the 24-h urine between the wildtype and the Aldh2 knockout mice in most of the urine samples. In the in vitro assays with the mitochondrial fraction from knockout mice, little activity of ALDH with small aldehyde molecules was observed 6) . However, as shown in the present study, the EAA excreted by the Aldh2 knockout mice was not lower than that excreted by the wild-type mice, implying possible differences between in vitro and in vivo results. There may be two reasons for the conflicting implications of the results for metabolism and EGEE toxicity. One is the collection time of the urine samples. The activity of ALDH towards aldehydes is high, and in fact, the half life of EGEE was determined as only several hours in rats 16) . Thus the pooled urine of 24 h may have diminished the differences, if any, in EAA excretion rate. Another possibility is the existence of an alternative pathway, other than ALDH2, such as ALDH1. Although ALDH2 is believed to be responsible for the majority of aldehyde metabolism at low substrate concentrations, it is possible that ALDH1 or other enzymes may be involved under some conditions or at some stages of the metabolism of aldehydes.
Overall, the present results suggest that susceptibility to EGEE-induced sperm toxicity may differ according to the polymorphisms of Aldh2. Although this is a pilot study for the elucidation of EGEE-related reproductive toxicity, to our knowledge, it is the first report to show the effect of a knockout gene coding a catalyzing enzyme on the toxicity of EGEE. Further study focused on the detailed metabolic profile of EGEE is necessary for the elucidation of the genotypical differences in its toxicity.
